Edition:
United Kingdom

Nektar Therapeutics (NKTR.OQ)

NKTR.OQ on NASDAQ Stock Exchange Global Select Market

85.30USD
18 May 2018
Change (% chg)

$6.07 (+7.66%)
Prev Close
$79.23
Open
$79.82
Day's High
$86.11
Day's Low
$79.66
Volume
1,501,275
Avg. Vol
1,126,500
52-wk High
$111.36
52-wk Low
$17.52

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 4.68 December 19 May 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 7 6 4 4
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.75 1.73 1.67 1.67

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 10 938.34 1,102.57 184.00 57.99
Quarter Ending Sep-18 10 53.36 136.00 21.10 46.48
Year Ending Dec-18 10 1,084.23 1,392.00 296.00 192.44
Year Ending Dec-19 9 264.33 605.00 95.40 246.59
Earnings (per share)
Quarter Ending Jun-18 10 4.68 5.89 0.26 -0.20
Quarter Ending Sep-18 10 -0.48 0.10 -0.72 -0.28
Year Ending Dec-18 10 3.16 5.12 -1.67 -1.01
Year Ending Dec-19 9 -1.31 1.05 -3.38 -0.63

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 35.62 38.02 2.40 6.75
Quarter Ending Dec-17 36.98 95.47 58.49 158.18
Quarter Ending Sep-17 117.32 152.93 35.61 30.35
Quarter Ending Jun-17 34.23 34.59 0.36 1.05
Quarter Ending Mar-17 26.80 24.73 2.07 7.73

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 938.34 348.28 255.42 301.61 57.99
Quarter Ending Sep-18 53.36 82.40 87.56 102.20 46.48
Year Ending Dec-18 1,084.23 535.14 567.27 526.87 192.44
Year Ending Dec-19 264.33 322.96 325.03 352.18 246.59

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 8 1 9 0
Quarter Ending Sep-18 3 5 3 5
Year Ending Dec-18 7 2 7 2
Year Ending Dec-19 3 5 2 4
Earnings